T1	Participants 391 459	Fifty-seven patients younger than 65 years with early, nonerosive RA
T2	Participants 771 808	7 of the 57 patients (12.3%) withdrew
T3	Participants 836 1012	Of the remaining 50 patients, 42 (84.0%) were American College of Rheumatology (ACR) 20% responders, 30 (60.0%) were ACR 50% responders, and 23 (46.0%) were ACR 70% responders.
T4	Participants 1025 1036	22 patients
T5	Participants 1135 1157	16 patients taking CSA
T6	Participants 1342 1380	6 CSA patients who completed the trial
